BioWorld. Link to homepage. BioWorld. Link to homepage. Upgrade your daily dose of biopharma and medtech newsSilence is golden: Astrazeneca buys into siRNA platform with $80M down paymentPopular StoriesToday's news in briefToday's news in briefZelira’s stock triples as cannabinoid outperforms Lyrica in painCiting US constitutional violations, Merck the first to challenge the IRAReprocell reports mixed results for phase II Stemchymal trial in spinocerebellar ataxiaBioWorld Premium
Synthetic siRNA quantitation
Development of therapeutic-grade small interfering RNAs by chemical engineering